Preparing for a Pandemic: Accelerating Vaccine Availability

Athey acknowledges a generous gift from Schmidt Futures. Ahuja and Kremer acknowledge generous funding from the Wellspring Philanthropic Fund. Baker and Więcek acknowledge generous funding from Emergent Ventures. Kominers acknowledges generous funding from the Washington Center for Equitable Growth. Kremer is a Senior Advisor to the World Bank on vaccines; he is also a co-founder and scientific director of USAID’s Development Innovation Ventures. Lee is a senior economist at the World Bank and has some involvement in vaccine financing. Athey, Kremer, and Snyder served on a pro-bono advisory group on the design of COVAX. Budish, Kominers, and Prendergast serve on a pro-bono expert group advising on the design of the COVAX exchange mechanism. For contributing input and expertise, we are indebted to numerous experts in vaccine procurement from international organizations and governments. Whit Athey, Owen Barder, Tasneem Chipty, Lisa Danzig, Greg Larson, Jonathan Levin, Jessica Picket, and Duc Tran provided invaluable advice. The views expressed herein are those of the authors and do not necessarily reflect the views of the National Bureau of Economic Research.